Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1997
06/25/1997EP0780469A1 Immortalized human skin cell lines and serum-free medium for the production thereof
06/25/1997EP0780468A1 Transformant producing substance pf1022 and method for transforming microorganism belonging to the class hyphomycetes
06/25/1997EP0779935A1 Detection of hypermutable nucleic acid sequence in tissue
06/25/1997EP0779934A1 Compositions and methods for use in detection of analytes
06/25/1997EP0779933A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
06/25/1997EP0779931A1 Methods for calcium phosphate transfection
06/25/1997EP0779930A1 Methods and compositions for inhibiting production of replication competent virus
06/25/1997EP0779929A1 Non self-inactivating, expression targeted retroviral vectors
06/25/1997EP0779928A1 Acetohydroacid synthase promoter for expression of introduced genes in plants
06/25/1997EP0779927A1 A method of improved production of insulin-like growth factor
06/25/1997EP0779926A1 Transgenic plants expressing acc oxidase genes
06/25/1997EP0779925A2 A disease resistance gene from maize and its use for disease resistance, as a selectable marker and as a gene identification probe
06/25/1997EP0779924A2 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus
06/25/1997EP0779923A2 Interleukin-1 type 3 receptors
06/25/1997EP0779922A2 Modified human c3 proteins
06/25/1997EP0779921A1 CLONED SstI/SacI RESTRICTION-MODIFICATION SYSTEM
06/25/1997EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES
06/25/1997EP0779896A1 New process for the production of biologically active protein
06/25/1997EP0779893A2 Oligonucleotide prodrugs
06/25/1997EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
06/25/1997EP0755261A4 Bandage for continuous application of biologicals
06/25/1997EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy
06/25/1997EP0623145B1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications
06/25/1997CN1152946A Producing copies of nucleic acids
06/25/1997CN1152942A N-terminally extended proteins expressed in yeast
06/25/1997CN1152941A Genes for the synthesis of antipathogenic substances
06/25/1997CN1152940A Non-splicing variants of gp 350/220
06/25/1997CN1152939A Monoclonal antibodies which promote central nervous system remyelination
06/25/1997CN1152938A Growth control for cells encapsulated within bioartificial organs
06/25/1997CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
06/25/1997CN1152936A Granular formulation containing microorganisms, a process for the preparation and the use thereof
06/25/1997CN1152935A Papillomavirus vaccines
06/25/1997CN1152925A Monoclonal antibody active against CD44V6
06/25/1997CN1152924A Proteins from mammaliam liver and their use in oncology
06/25/1997CN1152879A Conjugates made of metal complexes and oligonucleotides
06/25/1997CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
06/25/1997CN1152875A Enhanced virus-mediated DNA transfer
06/25/1997CN1152613A Method and device for separating phenotype correlation gene
06/25/1997CN1035257C Midified plutelet factor-4
06/24/1997US5642035 Transfection high-voltage controller
06/24/1997US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same
06/24/1997US5641870 Low pH hydrophobic interaction chromatography for antibody purification
06/24/1997US5641869 Fractionation on immunoaffinity or ion exchange column, ethanol or ammonium sulfate precipitation, reverse phase liquid chromatography, chromatography on silica or heparin sepharose, chromatofocusing, gel filtration, electrophoresis
06/24/1997US5641867 Antitumor agents
06/24/1997US5641866 Bcl-2-associated proteins
06/24/1997US5641864 Kits for high temperature reverse transcription of RNA
06/24/1997US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same
06/24/1997US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia
06/24/1997US5641837 Method of detecting collagen degradation in vivo
06/24/1997US5641760 Method of treating candida infection
06/24/1997US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor
06/24/1997US5641754 Antitumor agents
06/24/1997US5641750 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
06/24/1997US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
06/24/1997US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation
06/24/1997US5641680 For gene therapy treatment
06/24/1997US5641676 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
06/24/1997US5641675 Inhibiting intracellular localization of target mrna molecule to periphery of cell in vitro by introducing antisense nucleotide complementary to zipcode region of molecule
06/24/1997US5641674 Nucleotide sequences and proteins conferring cycloheximide resistance
06/24/1997US5641673 Polynucleotide molecule encoding trans-splicing ribozyme with rna sequence hybridizing to target rna encoding transcription activator protein fused to sequence to be trans-spliced into target rna, linked to transcription regulator
06/24/1997US5641672 Nucleic acid molecule; vectors; plasmids; host vector system
06/24/1997US5641671 Includes lipase-specific stabilization/translocation protein
06/24/1997US5641670 Protein production and protein delivery
06/24/1997US5641669 Platelet-activating factor acetylhydrolase
06/24/1997US5641668 Proteins having glycosyltransferase activity
06/24/1997US5641666 Soraphen A resistant fungi and acetyl-CoA carboxylase
06/24/1997US5641665 Plasmids suitable for IL-2 expression
06/24/1997US5641664 Wounding or degrading type i callus and transferring dna into nuclear genome of corn cell
06/24/1997US5641663 Regulatory polynucleotide comprising linked promoter and signal polynucleotides operatively linked to polynucleotide encoding eukaryotic protein
06/24/1997US5641662 Transfection of lung via aerosolized transgene delivery
06/24/1997US5641661 Pichia pastoris alcohol oxidase ZZA1 and ZZA2 regulatory regions for heterologous gene expression
06/24/1997US5641660 Glutamicum threonine biosynthetic pathway
06/24/1997US5641658 Method for performing amplification of nucleic acid with two primers bound to a single solid support
06/24/1997US5641657 DNA encoding an interleukin-6 splice variant
06/24/1997US5641656 Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
06/24/1997US5641655 Genetic engineered dna encoding a protein fusion
06/24/1997US5641654 Medical diagnosis; accuracy
06/24/1997US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia
06/24/1997US5641651 Synthetic herpes simplex virus promoters
06/24/1997US5641650 Expression of heterologous polypeptides in halobacteria
06/24/1997US5641649 Expression of osteogenic factor OP-1 in cells of spodoptera frugiperda infected with recombinant baculovirus
06/24/1997US5641648 Dna sequences coding for the expression of the large polypeptides; genetic engineering
06/24/1997US5641646 Purification of fused protein and human glicentin is carried out by utilizing a reversible covalent bond of a cysteine residue with the stationary phase of a chromatography column
06/24/1997US5641638 Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof
06/24/1997US5641633 Fluorescence polarization detection of nucleic acids
06/24/1997US5641629 Spectroscopically detectable nucleic acid ligands
06/24/1997US5641627 Measuring expression level of reporter gene when mycotic cells are treated with potential translation(genetic) inhibitors
06/24/1997US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage
06/24/1997US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof
06/24/1997US5641490 Recombinant avipox virus comprising exogenous dna from infectious bursal disease virus inserted into nonessential region of avipox virus genome, which expresses structural protein coded for by said exogenous dna
06/24/1997US5641487 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
06/24/1997US5641459 Machine for synthesizing oligonucleotides
06/24/1997US5640804 Pest trap plants and crop protection
06/21/1997CA2191903A1 Stress proteins
06/20/1997CA2193315A1 Human mucin (muc8)
06/19/1997WO1997022004A1 Assays for growth hormone secretagogue receptors
06/19/1997WO1997021837A1 Methods for the detection and removal of mutant sequences that arise during enzymatic amplification using mismatch repair systems
06/19/1997WO1997021836A1 Molecular sequence of swine retrovirus and methods of use
06/19/1997WO1997021829A1 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
06/19/1997WO1997021826A2 Complementary adenoviral vector systems and cell lines